Caricamento...
DMF: a promising therapeutic option in CTCL
In this issue of Blood, Nicolay et al present their exciting findings that show that dimethyl fumarate (DMF) specifically inhibits NF-κB activity in cutaneous T-cell lymphoma (CTCL) cells, thus inducing their apoptosis, while having minimal effect on healthy T cells (see figure). Their study suggest...
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982450/ https://ncbi.nlm.nih.gov/pubmed/27516426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-06-722462 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|